載入...
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307
BACKGROUND: Adjuvant bisphosphonates, when given in a low-estrogen environment, can decrease breast cancer recurrence and death. Treatment guidelines include recommendations for adjuvant bisphosphonates in postmenopausal patients. SWOG/Alliance/Canadian Cancer Trials Group/ECOG-ACRIN/NRG Oncology st...
Na minha lista:
| 發表在: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357327/ https://ncbi.nlm.nih.gov/pubmed/31693129 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz215 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|